City Holding Co. Sells 227 Shares of Colgate-Palmolive (NYSE:CL)

City Holding Co. decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,110 shares of the company’s stock after selling 227 shares during the quarter. City Holding Co.’s holdings in Colgate-Palmolive were worth $646,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. FMR LLC boosted its position in shares of Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. Barclays PLC lifted its stake in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. State Street Corp boosted its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB increased its stake in shares of Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after purchasing an additional 1,247,731 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of Colgate-Palmolive by 58.6% during the 2nd quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock worth $234,540,000 after buying an additional 892,706 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.37% of the stock is owned by insiders.

Colgate-Palmolive Trading Up 0.3 %

NYSE CL opened at $88.79 on Tuesday. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business has a 50 day simple moving average of $92.20 and a 200 day simple moving average of $97.76. The stock has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. Colgate-Palmolive’s payout ratio is presently 57.31%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CL shares. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Finally, Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.